AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

WILMINGTON PLC

Transaction in Own Shares Aug 3, 2021

4748_mrq_2021-08-03_f2375a72-376a-49f6-b33a-d74fa231cff9.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4351H

Wilmington PLC

03 August 2021

3 August 2021

Wilmington plc

Employee Share Ownership Trust Purchase

Further to the announcement made on 11 May 2021 outlining the re-commencement of a planned programme of share purchases to be made by the Wilmington Group plc Employee Share Ownership Trust ('the Trust'), on 3 August 2021 Wilmington plc ('the Company') was notified by SG Kleinwort Hambros Trust Company (CI) Limited acting as Trustee that on 2 August 2021 the Trust completed the purchase of 3,437 ordinary shares of 5p each in the Company at an average price of £2.20.

The Trust holds the shares for the benefit of the Company's employees and in particular for the satisfying of awards made under the Company's various share schemes.

The Trust now holds 500,000 ordinary shares in the Company representing 0.57% of the Company's current voting rights.

For further information, please contact:

Wilmington plc  020 7490 0049

Guy Millward, Company Secretary and Chief Financial Officer

Notes to Editors

Wilmington is the recognised knowledge leader and partner of choice for data, information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLSSSFFDEFSEEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.